Current processes for finding novel antibody targets or developing stable cell lines are time consuming and inefficient. Whether you are screening whole B cell repertoires, hybridomas, CHO or other cells, approaches such as cell sorting, clone picking or limiting dilutions have their associated drawbacks – some do not allow cell secretion assays, some tend to be harsh on the individual cells impacting cell viability and outgrowth. Existing approaches are suboptimal, costly, require various individual steps, therefore potentially introducing human error and contamination.
Cyto-Mine® is the new generation solution which allows you to accelerate, automate and simplify your antibody discovery and cell line development workflows.
Targeted Discovery. Rapidly identify and isolate your rare cells of interest.
Extensive proof of monoclonality for cell line development.
Significantly Reduce Timelines and Costs. Tens of millions of cells in pools or hundreds of thousands individually are screened in a single day.
Flexibility. Flexible assay design allows quantitative measurement of antibody secretion.
Sterility. The entire process is automated, sterile and Animal Origin Free. The Benchtop system is compatible for use in Class II biosafety cabinets.
The first integrated device to automatically perform selective screening, cell isolation (CHO,Hybridomas, Bcells…) and monoclonality verification in a single compact system